Literature DB >> 10438308

Corticosteroids and ibuprofen in cystic fibrosis.

I M Balfour-Lynn, C Dezateux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10438308      PMCID： PMC1745514          DOI： 10.1136/thx.54.7.655d

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  6 in total

Review 1.  "CF asthma": what is it and what do we do about it?

Authors:  I M Balfour-Lynn; J S Elborn
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 2.  Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.

Authors:  Adam Jaffe; Ian M Balfour-Lynn
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Inhaled corticosteroids for cystic fibrosis.

Authors:  Ian M Balfour-Lynn; Karen Welch; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-07-04

4.  A pilot trial on safety and efficacy of erythrocyte-mediated steroid treatment in CF patients.

Authors:  V Lucidi; A E Tozzi; S Bella; A Turchetta
Journal:  BMC Pediatr       Date:  2006-05-24       Impact factor: 2.125

Review 5.  Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review.

Authors:  Janice Abbott; Anna Hart
Journal:  Health Qual Life Outcomes       Date:  2005-03-24       Impact factor: 3.186

6.  Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation.

Authors:  Kerstin Pohl; David P Nichols; Jennifer L Taylor-Cousar; Milene T Saavedra; Matthew J Strand; Jerry A Nick; Preston E Bratcher
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.